MODULO Facoltà di Medicina e Chirurgia Data di nascita 14 ...

Facoltà di Medicinae ChirurgiaMODULOSCHEDE PERSONALI DOCENTITEC. LAB. BIO.Data14.10.2008 Pag. 15 di 54Pubblicazioni, più rilevanti, del proprio excursus accademico- Aquino A., Prete S.P., Giuliani A., Graziani G., Turriziani M., De Filippi R., Masci G., Greiner J.W.,Bonmassar E., De Vecchis L.: Effect of the combined treatment with 5-Fluorouracil, gammainterferonor folinic acid on carcinoembryonic antigen expression in colon cancer cells.Clin. Cancer Res. 4(10):2473-2481, 1998.- Aquino A., Prete S.P., Baier S., Cappelletti D., Greiner J.W., De Vecchis L., Graziani G., Bonmassar E.,:Staurosporine increases carcinoembryonic antigen expression in a human colon cancer cell line.J. Chemotherapy 12(2):167-172, 2000.- Cappelletti D., Cardillo A., Bonanno E., Prete S.P., Cucchiara G., Turriziani M., Greiner J.W., Breda E.,Aquino A., Bonmassar E., De Vecchis L.: Drug-induced modulation of carcinoembryonic antigen(CEA) expression in neoplastic cells from a patient with rectal cancer.J. Exp. Clin. Cancer Res. 19(4):467-469, 2000.- Correale P, Sabatino M, Cusi MG, Micheli L, Nencini C, Pozzessere D, Petrioli R, Aquino A, De Vecchis L,Turriziani M, Prete SP, Sanguedolce R, Rausa L, Giorgi G, Francini G.:In vitro generation of cytotoxic Tlymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthase.J Chemother. 13(5):519-26, 2001.- Prete SP, Cappelletti D, Baier S, Nasuti P, Guadagni F, De Vecchis L, Greiner JW, Bonmassar E, GrazianiG, Aquino A.: Pharmacological modulation of carcinoembryonic antigen in human cancer cells: studies withstaurosporine. Int Immunopharmacol. 2(5):641-51, 2002.- Correale P, Aquino A, Giuliani A, Pellegrini M, Micheli L, Cusi MG, Nencini C, Petrioli R, Prete SP, DeVecchis L, Turriziani M, Giorgi G, Bonmassar E, Francini G.: Treatment of colon and breast carcinoma cellswith 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01restricted, CEA-peptide-specific cytotoxic T cells in vitro. Int J Cancer. 104(4):437-45, 2003.- Turriziani M, Di Giacomo AM, Cardillo A, Torino F, Tentori L, Nasuti P, Massara MC, Roselli M, BonmassarE, De Vecchis L.: Residual telomerase activity: a marker of cell survival after exposure to gamma radiationin vitro. Anticancer Res.23(6C):4561-70, 2003.- Aquino A, Formica V, Prete SP, Correale PP, Massara MC, Turriziani M, De Vecchis L, Bonmassar E.: Druginduced increase of carcinoembryonic antigen expression in cancer cells. Pharmacol Res. 49(5):383-96,2004.- Prete S.P., Rossi L., Correale P., Turriziani M., Baier S., Tamburelli G., De Vecchis L., Bonmassar E.,Aquino A.: Combined effects of protein kinase inhibitors and 5-fluorouracil on CEAexpression in human colon cancer cells. Pharmacol. Res. 52:167-73, 2005.- De Rossi A., Rossi L., Laudisi A., Sini V., Toppo L., Marchesi F., Tortorelli G., Leti M., Turriziani M.,Aquino A., Bonmassar E., De Vecchis L., Torino F.: Focus on fotemustine. J. Exper. Clin. Cancer Res.25:461-68, 2006.- Marchesi F., Turriziani M., Testorelli G., Avvisati G., Torino F., De Vecchis L.: Triazene compounds:mechanism of action and related DNA reapair systems. Pharmacol. Res. 56(4):275-87, 2007. (- Prete S.P., Turriziani M., Massara M.C., De ossi A., Correale P., De Vecchis L., Torino F., Bonmassar E.,Aquino A.: Combined effects of 5-fluorouracile , folinic acid and oxaliplatin on the expression ofcarcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an acuteantitumor imunohemotherapy. J. Exp. Clin. Cancer Res.27:5, 2008